1. Home
  2. RZLT vs GES Comparison

RZLT vs GES Comparison

Compare RZLT & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • GES
  • Stock Information
  • Founded
  • RZLT 2010
  • GES 1981
  • Country
  • RZLT United States
  • GES Switzerland
  • Employees
  • RZLT N/A
  • GES N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • GES Apparel
  • Sector
  • RZLT Health Care
  • GES Consumer Discretionary
  • Exchange
  • RZLT Nasdaq
  • GES Nasdaq
  • Market Cap
  • RZLT 819.3M
  • GES 872.4M
  • IPO Year
  • RZLT N/A
  • GES 1996
  • Fundamental
  • Price
  • RZLT $9.53
  • GES $17.04
  • Analyst Decision
  • RZLT Strong Buy
  • GES Buy
  • Analyst Count
  • RZLT 7
  • GES 5
  • Target Price
  • RZLT $14.86
  • GES $19.25
  • AVG Volume (30 Days)
  • RZLT 1.5M
  • GES 591.2K
  • Earning Date
  • RZLT 11-07-2025
  • GES 11-25-2025
  • Dividend Yield
  • RZLT N/A
  • GES 5.28%
  • EPS Growth
  • RZLT N/A
  • GES N/A
  • EPS
  • RZLT N/A
  • GES 0.35
  • Revenue
  • RZLT N/A
  • GES $3,091,508,000.00
  • Revenue This Year
  • RZLT N/A
  • GES $7.97
  • Revenue Next Year
  • RZLT N/A
  • GES $3.46
  • P/E Ratio
  • RZLT N/A
  • GES $49.13
  • Revenue Growth
  • RZLT N/A
  • GES 7.84
  • 52 Week Low
  • RZLT $2.22
  • GES $8.48
  • 52 Week High
  • RZLT $10.04
  • GES $18.07
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 60.19
  • GES 70.39
  • Support Level
  • RZLT $9.00
  • GES $16.75
  • Resistance Level
  • RZLT $9.89
  • GES $16.89
  • Average True Range (ATR)
  • RZLT 0.57
  • GES 0.09
  • MACD
  • RZLT 0.02
  • GES -0.03
  • Stochastic Oscillator
  • RZLT 82.97
  • GES 97.56

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: